BioNTech SE


Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules.

streetwise book logo Streetwise Company Fact Sheet

2024/2/27 8:45:44


Streetwise Reports Articles

06/30/2022 - View Article
05/01/2022 - View Article